OSE IMMUNO - 1H - Technical analysis published on 09/22/2023 (GMT)
- 207
- 0
- Timeframe : 1H
- - Analysis generated on
- Status : NEUTRAL
Analysis too old. There are no more charts available.
Summary of the analysis
Additional analysis
Quotes
The OSE IMMUNO rating is 4.420 EUR. The price registered an increase of +6.51% on the session with the lowest point at 3.950 EUR and the highest point at 4.420 EUR. The deviation from the price is +11.90% for the low point and 0% for the high point.So that you have an overall view of the price change, here is a table showing the variations over several periods:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
Technical analysis of OSE IMMUNO in 1H shows an overall slightly bearish trend. 60.71% of the signals given by moving averages are bullish. As the signals currently given by short-term moving averages are rather neutral, the overall trend could quickly return to neutral as well. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
On the 18 technical indicators analysed, 8 are bullish, 4 are neutral and 6 are bearish. Caution: the Central Indicators scanner currently detects an excess:
RSI indicator: bullish divergence
Type : Bullish
Timeframe : 1 hour
MACD crosses UP its Moving Average
Type : Bullish
Timeframe : 1 hour
Parabolic SAR indicator bullish reversal
Type : Bullish
Timeframe : 1 hour
Price is back under the pivot point
Type : Bearish
Timeframe : Weekly
The analysis of the price chart with Central Patterns scanners does not return any result.
For a small rebound in the very short term, the Central Candlesticks scanner currently notes the presence of this bullish pattern in Japanese candlesticks:
Bullish engulfing lines
Type : Bullish
Timeframe : 1 hour
S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|
ProTrendLines | 2.993 | 3.728 | 4.420 | 4.520 | 4.870 | 5.330 |
Change (%) | -32.29% | -15.66% | - | +2.26% | +10.18% | +20.59% |
Change | -1.427 | -0.692 | - | +0.100 | +0.450 | +0.910 |
Level | Major | Major | - | Minor | Major | Intermediate |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 3.567 | 3.793 | 3.972 | 4.198 | 4.377 | 4.603 | 4.782 |
Camarilla | 4.039 | 4.076 | 4.113 | 4.150 | 4.187 | 4.224 | 4.261 |
Woodie | 3.543 | 3.781 | 3.948 | 4.186 | 4.353 | 4.591 | 4.758 |
Fibonacci | 3.793 | 3.948 | 4.044 | 4.198 | 4.353 | 4.449 | 4.603 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | -1.408 | 0.808 | 2.877 | 5.093 | 7.162 | 9.378 | 11.447 |
Camarilla | 3.767 | 4.159 | 4.552 | 4.945 | 5.338 | 5.731 | 6.123 |
Woodie | -1.483 | 0.771 | 2.803 | 5.056 | 7.088 | 9.341 | 11.373 |
Fibonacci | 0.808 | 2.445 | 3.457 | 5.093 | 6.730 | 7.742 | 9.378 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 2.208 | 2.457 | 2.648 | 2.897 | 3.088 | 3.337 | 3.528 |
Camarilla | 2.719 | 2.759 | 2.800 | 2.840 | 2.880 | 2.921 | 2.961 |
Woodie | 2.180 | 2.443 | 2.620 | 2.883 | 3.060 | 3.323 | 3.500 |
Fibonacci | 2.457 | 2.625 | 2.729 | 2.897 | 3.065 | 3.169 | 3.337 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 38.73 | |
MACD (12,26,9): | -0.2170 | |
Directional Movement: | -15.633 | |
AROON (14): | -92.857 | |
DEMA (21): | 4.024 | |
Parabolic SAR (0,02-0,02-0,2): | 4.180 | |
Elder Ray (13): | -0.122 | |
Super Trend (3,10): | 4.524 | |
Zig ZAG (10): | 4.240 | |
VORTEX (21): | 0.8260 | |
Stochastique (14,3,5): | 21.76 | |
TEMA (21): | 4.020 | |
Williams %R (14): | -44.37 | |
Chande Momentum Oscillator (20): | -0.070 | |
Repulse (5,40,3): | 8.5590 | |
ROCnROLL: | -1 | |
TRIX (15,9): | -0.7060 | |
Courbe Coppock: | 20.21 |
MA7: | 4.750 | |
MA20: | 3.938 | |
MA50: | 3.388 | |
MA100: | 3.494 | |
MAexp7: | 4.161 | |
MAexp20: | 4.316 | |
MAexp50: | 4.603 | |
MAexp100: | 4.511 | |
Price / MA7: | -6.95% | |
Price / MA20: | +12.24% | |
Price / MA50: | +30.46% | |
Price / MA100: | +26.50% | |
Price / MAexp7: | +6.10% | |
Price / MAexp20: | +2.29% | |
Price / MAexp50: | -4.08% | |
Price / MAexp100: | -2.13% |
News
Don't forget to follow the news on OSE IMMUNO. At the time of publication of this analysis, the latest news was as follows:
- OSE Immunotherapeutics Announces New Public Grant to Support Innovation and Research Programs in the Field of RNA Therapeutics
- OSE Immunotherapeutics Announces Publication in Frontiers in Immunology on OSE-230, its Novel Agonist Therapy in Chronic Inflammation
- OSE Immunotherapeutics and Nantes University Hospital Announce Completion of Patient Enrollment in the FIRsT Clinical Trial, a Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplantation
- OSE Immunotherapeutics Announces for Lusvertikimab, its Anti-IL-7 Receptor Antagonist:
- OSE Immunotherapeutics Announces New US Patent Granted for the Use of Tedopi® in Cancer Patients after Failure with PD-1/PD-L1 Immune Checkpoint Inhibitor Treatment
Add a comment
Comments
0 comments on the analysis OSE IMMUNO - 1H